Abbott Laboratories
ABTUS ListedAbbott Laboratories (ABT) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 index.
Stock Snapshot & Key Numbers — Abbott Laboratories
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
Abbott Laboratories (ABT) is a US equity security listed on the NYSE. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at $104.89, recording a +0.21 (+0.20%) advance from its previous close of $104.68. Over the trailing 52-week trading cycle, ABT has traded between a 52-week low of $82.56 and a 52-week high of $130.59, establishing its annual trading channel. In historical performance, Abbott Laboratories has fallen 17.82% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +5.31%, 1-month: +2.47%, 6-month: +9.87%, 1-year: -17.82%, 3-year: +13.79%, 5-year: -10.21%. Daily reported trading volume reached 8,242,700 equity shares. On key valuation multiples as of Oct 13, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 32.8x and a price-to-book (P/B) ratio of 3.4x, with a trailing dividend yield of 2.53%. Its market capitalization stands at $176.19B. The company is categorized under the Health Care sector and S&P 500 industry within the US equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
At-a-Glance Health & Momentum Check
Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| S&P 500 | +0.04 | +0.02 | Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.04% co-movement (correlation: 0.02). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | -0.31 | -0.17 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.31% co-movement (correlation: -0.17). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.06 | -0.11 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.06% co-movement (correlation: -0.11). Descriptive historical relationship, not predictive. |
| USD / INR | -0.24 | -0.07 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.24% co-movement (correlation: -0.07). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹99.60 | ₹104.89 | +5.31% |
| 15 Days | ₹96.69 | ₹104.89 | +8.48% |
| 1 Month | ₹102.36 | ₹104.89 | +2.47% |
| 3 Months | ₹98.83 | ₹104.89 | +6.13% |
| 6 Months | ₹95.47 | ₹104.89 | +9.87% |
| 1 Year | ₹127.63 | ₹104.89 | -17.82% |
| 3 Years | ₹92.18 | ₹104.89 | +13.79% |
| 5 Years | ₹116.82 | ₹104.89 | -10.21% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹124.19 | ₹104.89 | -15.5% | |
| CY 2025 | ₹113.44 | ₹125.29 | +10.4% | |
| CY 2024 | ₹109.85 | ₹113.11 | +3.0% | |
| CY 2023 | ₹109.58 | ₹110.07 | +0.5% | |
| CY 2022 | ₹139.04 | ₹109.79 | -21.0% | |
| CY 2021 | ₹116.82 | ₹140.74 | +20.5% |
Corporate Actions History
No dividend or stock split distributions recorded in historical feeds for ABT.
Historical Investment Simulator
Factual simulation of past returns in Abbott Laboratories (ABT) using real recorded closing prices.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Capillary Technologies posts Rs 191 Cr revenue and Rs 43 Cr profit in Q4 FY26 - Entrackr
Capillary Technologies posts Rs 191 Cr revenue and Rs 43 Cr profit in Q4 FY26 Entrackr
3 Fundamentally Strong Medical Devices Stocks in India - Univest
3 Fundamentally Strong Medical Devices Stocks in India Univest
Abbott India Ltd (NSE: ABBOTINDIA): In-Depth Financial Analysis, Qualitative Business Assessment, and Investor Insights - Kalkine India
Abbott India Ltd (NSE: ABBOTINDIA): In-Depth Financial Analysis, Qualitative Business Assessment, and Investor Insights Kalkine India
Abbott India Analyst Review 2026: Key Insights - Univest
Abbott India Analyst Review 2026: Key Insights Univest
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Quarterly financial statements disclosed under statutory SEBI LODR Regulation 33.
- •Transaction / financial magnitude identified at ₹191 Cr
- •Quarterly financial results disclosed under SEBI LODR Regulation 33
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.
Identified project outlay of ₹191 Cr secures forward multi-quarter top-line visibility.
Common Questions About Abbott Laboratories (ABT)
Key facts on ABT share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of Abbott Laboratories (ABT)?
As of 16 Oct 2026, the official closing share price of Abbott Laboratories (ABT) on NYSE is $104.89 (+0.20% vs the previous close). Over the past 52 weeks, ABT has traded between a low of $82.56 and a high of $130.59, with a reported market capitalization of $176.19B.
What are the historical returns of Abbott Laboratories (ABT)?
Based on split-adjusted closing prices through 16 Oct 2026, Abbott Laboratories (ABT) recorded the following trailing price returns: 1 Week: +5.31% (from $99.60 to $104.89); 15 Days: +8.48% (from $96.69 to $104.89); 1 Month: +2.47% (from $102.36 to $104.89); 3 Months: +6.13% (from $98.83 to $104.89); 6 Months: +9.87% (from $95.47 to $104.89); 1 Year: -17.82% (from $127.63 to $104.89); 3 Years: +13.79% (from $92.18 to $104.89); 5 Years: -10.21% (from $116.82 to $104.89). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of Abbott Laboratories (ABT)?
Abbott Laboratories (ABT) currently trades at a trailing Price-to-Earnings (P/E) ratio of 32.8x, a Price-to-Book (P/B) ratio of 3.4x, and a trailing 12-month dividend yield of 2.53%. It operates in the Health Care sector (S&P 500).
How much would a past lump-sum or monthly SIP investment in ABT have grown?
Based on historical closing prices for Abbott Laboratories (ABT): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $8978.77 (-10.2% total return, -2.1% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $30500.00) would be worth $28542.19 (-6.4% absolute return). You can test custom amounts and holding periods in the interactive calculator above.